Rani Therapeutics Holdings Total Assets Growth & History (RANI)
Rani Therapeutics Holdings's total assets was $58.6M for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $58.6M | $22.0M | +60.02% |
| 2024 | 2024-12-31 | $36.6M | −$21.3M | −36.75% |
| 2023 | 2023-12-31 | $57.9M | −$50.1M | −46.39% |
| 2022 | 2022-12-31 | $108.0M | −$16.2M | −13.03% |
| 2021 | 2021-12-31 | $124.2M | $44.8M | +56.40% |
| 2020 | 2020-12-31 | $79.4M | — | — |
Rani Therapeutics Holdings quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $60.8M | $43.9M | +260.06% |
| Q1 2026 | 2026-03-31 | $51.9M | $27.8M | +115.04% |
| Q4 2025 | 2025-12-31 | $58.6M | $22.0M | +60.02% |
| Q3 2025 | 2025-09-30 | $10.1M | −$33.4M | −76.71% |
| Q2 2025 | 2025-06-30 | $16.9M | −$26.8M | −61.35% |
| Q1 2025 | 2025-03-31 | $24.1M | −$29.4M | −54.92% |
| Q4 2024 | 2024-12-31 | $36.6M | −$21.3M | −36.75% |
| Q3 2024 | 2024-09-30 | $43.5M | −$26.9M | −38.19% |
| Q2 2024 | 2024-06-30 | $43.7M | −$39.8M | −47.64% |
| Q1 2024 | 2024-03-31 | $53.5M | −$42.9M | −44.52% |
| Q4 2023 | 2023-12-31 | $57.9M | −$50.1M | −46.39% |
| Q3 2023 | 2023-09-30 | $70.4M | −$37.8M | −34.90% |
| Q2 2023 | 2023-06-30 | $83.5M | −$20.8M | −19.97% |
| Q1 2023 | 2023-03-31 | $96.4M | −$18.9M | −16.36% |
| Q4 2022 | 2022-12-31 | $108.0M | −$16.2M | −13.03% |
| Q3 2022 | 2022-09-30 | $108.2M | −$28.8M | −21.00% |
| Q2 2022 | 2022-06-30 | $104.3M | $27.0M | +34.95% |
| Q1 2022 | 2022-03-31 | $115.3M | — | — |
| Q4 2021 | 2021-12-31 | $124.2M | $44.8M | +56.40% |
| Q3 2021 | 2021-09-30 | $137.0M | — | — |
| Q2 2021 | 2021-06-30 | $77.3M | — | — |
| Q4 2020 | 2020-12-31 | $79.4M | — | — |
Rani Therapeutics Holdings total assets trends
Over the last five fiscal years, Rani Therapeutics Holdings's total assets decreased from $79.4M to $58.6M, a change of −$20.8M. The latest reported quarter, Q2 2026, shows $60.8M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗